Literature DB >> 33059090

Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study.

Bradley J Langford1, Nick Daneman2, Christina Diong3, Alex Marchand-Austin3, Kwaku Adomako4, Arezou Saedi4, Kevin L Schwartz5, Jennie Johnstone6, Derek R MacFadden7, Larissa M Matukas8, Samir N Patel9, Gary Garber10, Kevin A Brown5.   

Abstract

OBJECTIVE: Selective reporting of antibiotic susceptibility test results may help guide appropriate antibiotic prescribing, particularly for urinary tract infections. Our objective was to describe laboratory urine culture susceptibility reporting practices and to estimate their impact on antibiotic prescribing in outpatients.
METHODS: We examined all positive urine cultures with Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis associated with an antibiotic prescription among outpatients over 65 years of age in Ontario, Canada from 2014 through 2017. We evaluated antibiotic prescribing in the empirical window (1-3 days before culture result) and in the directed window (0-5 days after culture result). Unadjusted and adjusted odds ratios were reported to estimate the association between reporting and prescribing.
RESULTS: In total 113 780 eligible urine cultures from 48 laboratories were included in the study cohort. Susceptibility reporting practices were highly variable between laboratories, with a range across antibiotics from norfloxacin (n = 5/48, 10.4% reporting) to nitrofurantoin (n = 40/48, 83.3% reporting). Reporting antibiotic susceptibility was associated with increased odds of prescribing that antibiotic in the directed window (aOR 2.98, 95%CI 2.07-4.28). At the laboratory level, the proportion of urine cultures reporting specific antibiotic susceptibility results was also associated with an increase in prescribing of that antibiotic in the empirical window (adjusted OR 1.23, 95%CI 1.13-1.33, per 25% increase in reporting).
CONCLUSIONS: Laboratory reporting of antibiotic susceptibility results for urine cultures is associated with empirical and directed prescribing of the reported antibiotics. Laboratories can play an important role in guiding appropriate antibiotic selection for urinary indications. Crown
Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic prescribing; Antibiotic susceptibility testing; Antimicrobial stewardship; Microbiology laboratory; Selective reporting

Year:  2020        PMID: 33059090     DOI: 10.1016/j.cmi.2020.10.001

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Overly broad-spectrum antibiotic treatment of wild-type Pseudomonas aeruginosa infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort study.

Authors:  Clément Ourghanlian; Vincent Fihman; Antoine Morel; Charlotte Lafont; Adrien Galy; Eimma Calimouttoupoulle; Paul-Louis Woerther; Raphaël Lepeule
Journal:  JAC Antimicrob Resist       Date:  2022-10-17

2.  COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.

Authors:  Niccolò Buetti; Stéphane Ruckly; Etienne de Montmollin; Jean Reignier; Nicolas Terzi; Yves Cohen; Shidasp Siami; Claire Dupuis; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2021-01-27       Impact factor: 17.440

3.  Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Authors:  Eric Pelfrene; Radu Botgros; Marco Cavaleri
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-29       Impact factor: 4.887

4.  Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore.

Authors:  Tat Ming Ng; Sock Hoon Tan; Shi Thong Heng; Hui Lin Tay; Min Yi Yap; Boon Hou Chua; Christine B Teng; David C Lye; Tau Hong Lee
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-03       Impact factor: 4.887

5.  Timing and causes of death in severe COVID-19 patients.

Authors:  Charles de Roquetaillade; Swann Bredin; Jean-Baptiste Lascarrou; Thibaud Soumagne; Mariana Cojocaru; Benjamin Glenn Chousterman; Maxime Leclerc; Albin Gouhier; Gaël Piton; Frédéric Pène; Annabelle Stoclin; Jean-François Llitjos
Journal:  Crit Care       Date:  2021-06-30       Impact factor: 9.097

6.  A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients.

Authors:  Asimina Safarika; James W Wacker; Konstantinos Katsaros; Nicky Solomonidi; George Giannikopoulos; Antigone Kotsaki; Ioannis M Koutelidakis; Sabrina M Coyle; Henry K Cheng; Oliver Liesenfeld; Timothy E Sweeney; Evangelos J Giamarellos-Bourboulis
Journal:  Intensive Care Med Exp       Date:  2021-06-18

Review 7.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

Review 8.  Applying Diagnostic Stewardship to Proactively Optimize the Management of Urinary Tract Infections.

Authors:  Faiza Morado; Darren W Wong
Journal:  Antibiotics (Basel)       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.